​

Jaguar Health (JAGX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Jaguar Health Revenue Highlights

Latest Revenue (Y)

$11.51M

Latest Revenue (Q)

$3.04M

Main Segment (Y)

Mytesi

Jaguar Health Revenue by Period

Jaguar Health Revenue by Year

DateRevenueChange
2025-12-31$11.51M-1.52%
2024-12-31$11.69M19.75%
2023-12-31$9.76M-18.36%
2022-12-31$11.96M175.80%
2021-12-31$4.33M-53.81%
2020-12-31$9.38M62.51%
2019-12-31$5.78M30.77%
2018-12-31$4.42M1.26%
2017-12-31$4.36M2981.61%
2016-12-31$141.52K-45.23%
2015-12-31$258.38K100.00%
2014-12-31--

Jaguar Health generated $11.51M in revenue during NA 2025, up -1.52% compared to the previous quarter, and up 122.65% compared to the same period a year ago.

Jaguar Health Revenue by Quarter

DateRevenueChange
2025-09-30$3.04M2.08%
2025-06-30$2.98M37.22%
2025-03-31$2.17M-38.13%
2024-12-31$3.51M12.90%
2024-09-30$3.11M14.22%
2024-06-30$2.72M15.74%
2024-03-31$2.35M2.22%
2023-12-31$2.30M-18.24%
2023-09-30$2.81M5.12%
2023-06-30$2.68M35.70%
2023-03-31$1.97M-39.51%
2022-12-31$3.26M3.49%
2022-09-30$3.15M7.84%
2022-06-30$2.92M11.28%
2022-03-31$2.63M26.20%
2021-12-31$2.08M230.16%
2021-09-30$630.00K63.64%
2021-06-30$385.00K-68.98%
2021-03-31$1.24M-51.82%
2020-12-31$2.58M-7.10%
2020-09-30$2.77M-12.44%
2020-06-30$3.17M264.44%
2020-03-31$869.00K-42.34%
2019-12-31$1.51M54.92%
2019-09-30$972.78K-42.97%
2019-06-30$1.71M7.29%
2019-03-31$1.59M-0.38%
2018-12-31$1.60M40.97%
2018-09-30$1.13M28.08%
2018-06-30$883.85K9.88%
2018-03-31$804.36K-47.84%
2017-12-31$1.54M40.16%
2017-09-30$1.10M22.72%
2017-06-30$896.52K9.01%
2017-03-31$822.41K2747.98%
2016-12-31$28.88K-42.66%
2016-09-30$50.36K108.58%
2016-06-30$24.14K-36.71%
2016-03-31$38.15K-30.88%
2015-12-31$55.19K-28.94%
2015-09-30$77.67K23.00%
2015-06-30$63.14K1.21%
2015-03-31$62.39K100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Jaguar Health generated $3.04M in revenue during Q3 2025, up 2.08% compared to the previous quarter, and up 111.76% compared to the same period a year ago.

Jaguar Health Revenue Breakdown

Jaguar Health Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Mytesi$11.00M$11.30M$9.60M$11.70M$3.30M
Neonorm$35.00K$28.00K$42.00K$48.00K$62.00K
License$172.00K$129.00K---

Jaguar Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Mytesi (98.15%), License (1.53%), and Neonorm (0.31%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Neonorm$1.00K$4.00K$14.00K$16.00K$15.00K$4.00K$9.00K$24.00K$18.00K$8.00K$5.00K$15.00K$20.00K$8.00K$15.00K$6.00K$33.00K$15.00K$13.00K-
License$44.00K$42.00K$43.00K$43.00K----------------
Mytesi$3.10M$3.00M$2.80M$2.10M$6.00M$3.00M$2.30M$6.60M$2.60M$404.00K$3.20M$3.10M$384.00K$438.00K$1.50M$406.00K$317.00K$729.00K$2.60M$2.80M

Jaguar Health's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Mytesi (98.57%), License (1.40%), and Neonorm (0.03%).

Jaguar Health Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
INMInMed Pharmaceuticals$4.94B$820.19M
JAGXJaguar Health$11.51M$3.04M
SXTP60 Degrees Pharmaceuticals$607.57K$307.87K
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SILOSilo Pharma$72.10K$18.02K
KZIAKazia Therapeutics$555.00$5.00
CNSPCNS Pharmaceuticals--
GNPXGenprex--
GRIGRI Bio--

JAGX Revenue FAQ

What is Jaguar Health’s yearly revenue?

Jaguar Health's yearly revenue for 2025 was $11.51M, representing a decrease of -1.52% compared to 2024. The company's yearly revenue for 2024 was $11.69M, representing an increase of 19.75% compared to 2023. JAGX's yearly revenue for 2023 was $9.76M, representing a decrease of -18.36% compared to 2022.

What is Jaguar Health’s quarterly revenue?

Jaguar Health's quarterly revenue for Q3 2025 was $3.04M, a 2.08% increase from the previous quarter (Q2 2025), and a -2.16% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.98M, a 37.22% increase from the previous quarter (Q1 2025), and a 9.48% increase year-over-year (Q2 2024). JAGX's quarterly revenue for Q1 2025 was $2.17M, a -38.13% decrease from the previous quarter (Q4 2024), and a -7.66% decrease year-over-year (Q1 2024).

What is Jaguar Health’s revenue growth rate?

Jaguar Health's revenue growth rate for the last 3 years (2023-2025) was 17.93%, and for the last 5 years (2021-2025) was 165.54%.

What are Jaguar Health’s revenue streams?

Jaguar Health's revenue streams in c 25 are Mytesi, Neonorm, and License. Mytesi generated $11M in revenue, accounting 98.15% of the company's total revenue, down -2.65% year-over-year. Neonorm generated $35K in revenue, accounting 0.31% of the company's total revenue, up 25.00% year-over-year. License generated $172K in revenue, accounting 1.53% of the company's total revenue, up 33.33% year-over-year.

What is Jaguar Health’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Jaguar Health was Mytesi. This segment made a revenue of $11M, representing 98.15% of the company's total revenue.